Platelet-Rich Plasma: New Performance Understandings and Therapeutic Considerations in 2020.

Everts P, Onishi K, Jayaram P, Lana JF, Mautner K. · 2020

Read Platelet-Rich Plasma: New Performance Understandings and Therapeutic Considerations in 2020. by Everts P, Onishi K, Jayaram P, Lana JF, Mautner K. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7589810.txt.

Introduction

Everts, Onishi, Jayaram, Lana and Mautner review platelet-rich plasma therapy and new findings on its action. PRP uses a patient own blood fraction rich in platelets. It may aid repair in muscle, spine and wound care.

Platelet growth factors support the three phases of healing. Those phases are inflammation, growth and remodeling of tissue. Many PRP formulas have been tested in labs and animals. Human results often differ from lab-based guidance. The review covers platelet dosing and formula makeup. White cell effects on immunity and pain are discussed. Serotonin effects and drug interactions are covered too. Pairing PRP with rehabilitation plans is also reviewed for care.

Catalog record

CREATOREverts P, Onishi K, Jayaram P, Lana JF, Mautner K.
YEAR2020
COLLECTIONPAPERS
FORMATTXT
FILE SIZE131 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC7589810

Browse the full library · About the Tower of Babel